Archive: 05/12/2018
Adjuvant capecitabine did not improve outcomes for patients with early triple-negative breast cancer
Treating patients who had early-stage triple-negative breast cancer with the chemotherapy agent capecitabine after they completed surgery and standard chemotherapy did not significantly improve disease-free or overall survival ...
Dec 5, 2018